Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus.
Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus.
复制标题
钙通道拮抗剂、大麻素、阿片类药物和大鼠海马突触可塑性揭示了 GABAA 和 GABAB 反应的区别。
DOI:
10.1007/s00213-007-1040-4
复制
发表时间:
2008
影响因子:
3.4
通讯作者:
Alger,BradleyE
中科院分区:
文献类型:
--
作者:
Lafourcade,CarlosA;Alger,BradleyE
RationaleHippocampal interneurons release γ-aminobutyric acid (GABA) and produce fast GABAA- and slow GABAB-inhibitory postsynaptic potentials (IPSPs). The regulation of GABABeIPSPs or the interneurons that produce them are not well understood. In addition, while both μ-opioid receptors (μORs) and cannabinoid CB1R receptors (CB1Rs) are present on hippocampal interneurons, it is not clear how these two systems interact.ObjectivesThis study tests the hypotheses that: (1) all interneurons can initiate both GABAAand GABABinhibitory postsynaptic potentials; (2) GABABresponses are insensitive to mGluR-triggered, endocannabinoid (eCB)-mediated inhibitory long-term depression (iLTD); (3) GABABresponses are produced by interneurons that express μOR; and (4) CB1R-dependent and μOR-dependent response interact.Materials and methodsPharmacological and electrophysiological approaches were used in acute rat hippocampal slices. High resistance microelectrode recordings were made from pyramidal cells, while interneurons were stimulated extracellularly.ResultsGABABresponses were found to be produced by interneurons that release GABA via either presynaptic N-type or P/Q-type calcium channels but that they are insensitive to suppression by eCBs or eCB-mediated iLTD. GABABIPSPs were sensitive to suppression by a μOR agonist, suggesting a major source of GABABresponses is the μOR-expressing interneuron population. A small eCB-iLTD (10% eIPSP reduction) persisted in conotoxin. eCB-iLTD was blocked by a μOR agonist in 6/13 slices.ConclusionsGABABresponses cannot be produced by all interneurons. CB1R or μOR agonists will differentially alter the balance of activity in hippocampal circuits. CB1R- and μOR-mediated responses can interact.